• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估个体生物等效性标准的数值方法。

Numerical methods for the evaluation of individual bioequivalence criteria.

作者信息

Kimanani E K, Lavigne J, Potvin D

机构信息

Biometrics and Pharmacokinetics R&D, Phoenix International Life Sciences, 2350 Cohen Street, Saint-Laurent, Québec, H4R 2N6, Canada.

出版信息

Stat Med. 2000 Oct 30;19(20):2775-95. doi: 10.1002/1097-0258(20001030)19:20<2775::aid-sim545>3.0.co;2-g.

DOI:10.1002/1097-0258(20001030)19:20<2775::aid-sim545>3.0.co;2-g
PMID:11033575
Abstract

The evaluation of individual bioequivalence (IBE) by bootstrap resampling using common statistical software, for example SAS, is extremely time consuming. In this article, an estimation procedure that can be implemented in a high level language with the same degree of accuracy as SAS is described. The necessary parameter estimating equations under both least square (LSE) and restricted maximum likelihood (REML) methods are given. The algorithms used to numerically compute these values are outlined and tested, in FORTRAN, on several simulated data sets and shown to reproduce SAS results with at least 10(-3) precision. More importantly, the REML bootstrap algorithm reduces the time taken in SAS by a factor of 20. Secondary results indicate that LSE and REML parameter estimates are similar for mild unbalancedness. PROC MIXED, with unstructured (UN) and compound symmetry heterogeneous (CSH) variance structures give the same results except when the subject-by-treatment interaction variance, sigma(2)(D), is 0 in which case CSH significantly overestimates sigma(2)(D) and underestimates the within-treatment variances. It is concluded that bootstrap evaluation of IBE is efficiently done using either the LSE or REML algorithm in FORTRAN.

摘要

使用常见统计软件(例如SAS)通过自助重抽样来评估个体生物等效性(IBE)极其耗时。本文描述了一种可以用高级语言实现的估计程序,其准确性与SAS相当。给出了最小二乘法(LSE)和限制最大似然法(REML)下的必要参数估计方程。概述并测试了用于数值计算这些值的算法,该算法用FORTRAN语言在几个模拟数据集上进行了测试,结果表明它能以至少10^(-3)的精度重现SAS的结果。更重要的是,REML自助算法将SAS所需的时间减少了20倍。次要结果表明,对于轻度不平衡情况,LSE和REML参数估计值相似。除了在个体-处理交互方差sigma(2)(D)为0的情况下,使用非结构化(UN)和复合对称异质性(CSH)方差结构的PROC MIXED给出相同的结果,在这种情况下,CSH会显著高估sigma(2)(D)并低估处理内方差。得出的结论是,使用FORTRAN语言中的LSE或REML算法可以有效地完成IBE的自助评估。

相似文献

1
Numerical methods for the evaluation of individual bioequivalence criteria.评估个体生物等效性标准的数值方法。
Stat Med. 2000 Oct 30;19(20):2775-95. doi: 10.1002/1097-0258(20001030)19:20<2775::aid-sim545>3.0.co;2-g.
2
Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalence.个体生物等效性测定中的受试者与制剂相互作用:偏差与发生率
Pharm Res. 1999 Feb;16(2):186-90. doi: 10.1023/a:1018899504711.
3
Properties of the estimated variance component for subject-by-formulation interaction in studies of individual bioequivalence.个体生物等效性研究中受试者与制剂相互作用的估计方差分量的性质。
Stat Med. 2000 Oct 30;19(20):2867-78. doi: 10.1002/1097-0258(20001030)19:20<2867::aid-sim551>3.0.co;2-j.
4
Case studies, practical issues and observations on population and individual bioequivalence.关于群体和个体生物等效性的案例研究、实际问题及观察结果。
Stat Med. 2000 Oct 30;19(20):2811-20. doi: 10.1002/1097-0258(20001030)19:20<2811::aid-sim547>3.0.co;2-p.
5
The bootstrap procedure in individual bioequivalence.
Stat Med. 2000 Oct 30;19(20):2741-54. doi: 10.1002/1097-0258(20001030)19:20<2741::aid-sim542>3.0.co;2-3.
6
[Applying multilevel models in evaluation of bioequivalence (I)].[多层模型在生物等效性评价中的应用(I)]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Dec;30(12):1302-6.
7
Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studies.
Int J Clin Pharmacol Ther. 2001 Apr;39(4):162-6. doi: 10.5414/cpp39162.
8
A small sample confidence interval approach to assess individual bioequivalence.一种用于评估个体生物等效性的小样本置信区间方法。
Stat Med. 2000 Oct 30;19(20):2885-97. doi: 10.1002/1097-0258(20001030)19:20<2885::aid-sim553>3.0.co;2-h.
9
Some statistical considerations on the FDA draft guidance for individual bioequivalence.关于美国食品药品监督管理局个体生物等效性指南草案的一些统计学考量
Stat Med. 2000 Oct 30;19(20):2879-84. doi: 10.1002/1097-0258(20001030)19:20<2879::aid-sim552>3.0.co;2-9.
10
On statistical power for average bioequivalence testing under replicated crossover designs.重复交叉设计下平均生物等效性检验的统计功效
J Biopharm Stat. 2002 Aug;12(3):295-309. doi: 10.1081/bip-120014560.